▶ 調査レポート

不適切管理タイプII糖尿病治療の世界市場:市場規模・現状・予測

• 英文タイトル:Global Inadequately Controlled Type-II Diabetes Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。不適切管理タイプII糖尿病治療の世界市場:市場規模・現状・予測 / Global Inadequately Controlled Type-II Diabetes Treatment Market Size, Status and Forecast 2019-2025 / QYR9ST04901資料のイメージです。• レポートコード:QYR9ST04901
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、不適切管理タイプII糖尿病治療の世界市場について調査・分析し、不適切管理タイプII糖尿病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(大人、子供)、用途別(病院、研究)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の不適切管理タイプII糖尿病治療市場動向
・主要企業別マーケットシェア
・不適切管理タイプII糖尿病治療の種類別市場規模2014-2019
(大人、子供)
・不適切管理タイプII糖尿病治療の用途別市場規模2014-2019
(病院、研究)
・不適切管理タイプII糖尿病治療の北米市場:主要企業・種類別/用途別市場規模
・不適切管理タイプII糖尿病治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・不適切管理タイプII糖尿病治療の中国市場:主要企業・種類別/用途別市場規模
・不適切管理タイプII糖尿病治療の日本国内市場:主要企業・種類別/用途別市場規模
・不適切管理タイプII糖尿病治療の東南アジア市場:主要企業・種類別/用途別市場規模
・不適切管理タイプII糖尿病治療のインド市場:主要企業・種類別/用途別市場規模
・不適切管理タイプII糖尿病治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Sanofi S.A.、Boehringer Ingelheim GmbH、Eli Lilly and Company)
・不適切管理タイプII糖尿病治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Diabetes is a serious complex condition which can affect the entire body. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Insulin secreted by pancreas in hormone made by beta cell which is responsible for the conversion of glucose from food to energy. There are different types of diabetes, all type diabetes serious and complex body condition. The three main types of diabetes are type 1, type 2 and gestational diabetes.Type 2 is prolonged condition of body which inadequate production of insulin by pancreas to convert the glucose from food energy. Type 2 diabetes is strongly associated with genetic and family related risk factors. In general, type 2 diabetes develop occur in adults after the age of 45 but nowadays the prevalence of children and young adults suffering from diabetes are is increasing. In 2018, the global Inadequately Controlled Type-II Diabetes Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Inadequately Controlled Type-II Diabetes Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inadequately Controlled Type-II Diabetes Treatment development in United States, Europe and China.

The key players covered in this study
Sanofi S.A.
Boehringer Ingelheim GmbH
Eli Lilly and Company

Market segment by Type, the product can be split into
Adult
Child

Market segment by Application, split into
Hospital
Research

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Inadequately Controlled Type-II Diabetes Treatment status, future forecast, growth opportunity, key market and key players.
To present the Inadequately Controlled Type-II Diabetes Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Inadequately Controlled Type-II Diabetes Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Adult
1.4.3 Child
1.5 Market by Application
1.5.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Inadequately Controlled Type-II Diabetes Treatment Market Size
2.2 Inadequately Controlled Type-II Diabetes Treatment Growth Trends by Regions
2.2.1 Inadequately Controlled Type-II Diabetes Treatment Market Size by Regions (2014-2025)
2.2.2 Inadequately Controlled Type-II Diabetes Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Inadequately Controlled Type-II Diabetes Treatment Market Size by Manufacturers
3.1.1 Global Inadequately Controlled Type-II Diabetes Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Inadequately Controlled Type-II Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Inadequately Controlled Type-II Diabetes Treatment Key Players Head office and Area Served
3.3 Key Players Inadequately Controlled Type-II Diabetes Treatment Product/Solution/Service
3.4 Date of Enter into Inadequately Controlled Type-II Diabetes Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-2019)
4.2 Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Inadequately Controlled Type-II Diabetes Treatment Market Size (2014-2019)
5.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in United States
5.3 United States Inadequately Controlled Type-II Diabetes Treatment Market Size by Type
5.4 United States Inadequately Controlled Type-II Diabetes Treatment Market Size by Application

6 Europe
6.1 Europe Inadequately Controlled Type-II Diabetes Treatment Market Size (2014-2019)
6.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in Europe
6.3 Europe Inadequately Controlled Type-II Diabetes Treatment Market Size by Type
6.4 Europe Inadequately Controlled Type-II Diabetes Treatment Market Size by Application

7 China
7.1 China Inadequately Controlled Type-II Diabetes Treatment Market Size (2014-2019)
7.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in China
7.3 China Inadequately Controlled Type-II Diabetes Treatment Market Size by Type
7.4 China Inadequately Controlled Type-II Diabetes Treatment Market Size by Application

8 Japan
8.1 Japan Inadequately Controlled Type-II Diabetes Treatment Market Size (2014-2019)
8.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in Japan
8.3 Japan Inadequately Controlled Type-II Diabetes Treatment Market Size by Type
8.4 Japan Inadequately Controlled Type-II Diabetes Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size (2014-2019)
9.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in Southeast Asia
9.3 Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size by Type
9.4 Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size by Application

10 India
10.1 India Inadequately Controlled Type-II Diabetes Treatment Market Size (2014-2019)
10.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in India
10.3 India Inadequately Controlled Type-II Diabetes Treatment Market Size by Type
10.4 India Inadequately Controlled Type-II Diabetes Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size (2014-2019)
11.2 Inadequately Controlled Type-II Diabetes Treatment Key Players in Central & South America
11.3 Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size by Type
11.4 Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size by Application

12 International Players Profiles
12.1 Sanofi S.A.
12.1.1 Sanofi S.A. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inadequately Controlled Type-II Diabetes Treatment Introduction
12.1.4 Sanofi S.A. Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019)
12.1.5 Sanofi S.A. Recent Development
12.2 Boehringer Ingelheim GmbH
12.2.1 Boehringer Ingelheim GmbH Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inadequately Controlled Type-II Diabetes Treatment Introduction
12.2.4 Boehringer Ingelheim GmbH Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019)
12.2.5 Boehringer Ingelheim GmbH Recent Development
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inadequately Controlled Type-II Diabetes Treatment Introduction
12.3.4 Eli Lilly and Company Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019)
12.3.5 Eli Lilly and Company Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Inadequately Controlled Type-II Diabetes Treatment Key Market Segments
Table Key Players Inadequately Controlled Type-II Diabetes Treatment Covered
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size Market Share by Type 2014-2025
Figure Adult Figures
Table Key Players of Adult
Figure Child Figures
Table Key Players of Child
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Research Case Studies
Figure Inadequately Controlled Type-II Diabetes Treatment Report Years Considered
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size 2014-2025 (Million US$)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Regions 2014-2019
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Regions 2014-2019
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Manufacturers (2014-2019)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Share by Manufacturers in 2018
Table Global Inadequately Controlled Type-II Diabetes Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Inadequately Controlled Type-II Diabetes Treatment Product/Solution/Service
Table Date of Enter into Inadequately Controlled Type-II Diabetes Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size Share by Type (2014-2019)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size Market Share by Type (2014-2019)
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size Share by Application (2014-2019)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size Market Share by Application (2014-2019)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Application in 2018
Figure United States Inadequately Controlled Type-II Diabetes Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2018-2019)
Table United States Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2014-2019)
Table United States Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2014-2019)
Figure Europe Inadequately Controlled Type-II Diabetes Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2018-2019)
Table Europe Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2014-2019)
Table Europe Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2014-2019)
Figure China Inadequately Controlled Type-II Diabetes Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2018-2019)
Table China Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-20189) (Million US$)
Table China Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2014-2019)
Table China Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019) (Million US$)
Table China Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2014-2019)
Figure Japan Inadequately Controlled Type-II Diabetes Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2018-2019)
Table Japan Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2014-2019)
Table Japan Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2018-2019)
Table Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2014-2019)
Table Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2014-2019)
Figure India Inadequately Controlled Type-II Diabetes Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2018-2019)
Table India Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-2019) (Million US$)
Table India Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2014-2019)
Table India Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019) (Million US$)
Table India Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2014-2019)
Figure Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Inadequately Controlled Type-II Diabetes Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Inadequately Controlled Type-II Diabetes Treatment Market Share (2018-2019)
Table Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Share by Type (2014-2019)
Table Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Share by Application (2014-2019)
Table Sanofi S.A. Company Details
Table Sanofi S.A. Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019) (Million US$)
Figure Sanofi S.A. Revenue Growth Rate in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019)
Table Sanofi S.A. Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Boehringer Ingelheim GmbH Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019)
Table Boehringer Ingelheim GmbH Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Inadequately Controlled Type-II Diabetes Treatment Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size Share by Regions (2019-2025)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size Share by Regions in 2025
Figure United States Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Product (2019-2025)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Product in 2025
Table Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Application (2019-2025)
Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources